Ben Halladay
Chief Financial Officer
CFO
Executive changes
Earnings-call appearances
-
Esperion Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-06
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-07
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-12
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Esperion Therapeutics, Inc. (ESPR)